BiancaWeinstock GuttmanMDProfessor of Neurology, Suny Buffalo

Neurology • Buffalo, NY

Neuroimmunology/Multiple Sclerosis

Director Jacobs MS Center for treatment and research

Join to view full profile

Dr. Weinstock Guttman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Weinstock Guttman's full profile

Already have an account?

Office
1001 Main St
Buffalo, NY 14203
Phone+1 716-878-2497

Summary

I am board certified in Neurology from Israel
Fellowship in Multiple Sclerosis and Neuroimmunology at Cleveland Clinic
Internal medicine 1 year University if Buffalo

Education & Training

Carol Davila University of Medicine and PharmacyClass of 1983, MD, Cum Laude

Certifications & Licensure

NY State Medical License 1998 - 2025
OH State Medical License 1996 - 2011

Clinical Trials

Effects of Dalfampridine on Cognition in Multiple Sclerosis Start of enrollment: 2011 Dec 01
Completed
Phase 2, Phase 3
Natalizumab Temporary Discontinuation Study Start of enrollment: 2012 Nov 01
Completed
Phase 4
Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) Start of enrollment: 2016 Dec 01
Terminated
Phase 3
Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis Start of enrollment: 2015 Aug 01
Completed
Phase 4
Join now to see all

Publications & Presentations

PubMed

Explainable time-to-progression predictions in multiple sclerosis.
Robbe D'hondt, Klest Dedja, Sofie Aerts, Bart Van Wijmeersch, Tomas Kalincik
Computer Methods and Programs in Biomedicine. 2025-05-01
1 citations
The relationship between optical coherence tomography and magnetic resonance imaging measurements in people with multiple sclerosis: A systematic review and meta-analy...
Omid Mirmosayyeb, Mohammad Yazdan Panah, Elham Moases Ghaffary, Saeed Vaheb, Farhad Mahmoudi
Journal of the Neurological Sciences. 2025-03-15
Immune response to influenza vaccine in patients with relapsing multiple sclerosis treated with ofatumumab: Results from an open-label, multicenter, phase 4 study.
Brian Steingo, Adnan Subei, Emily Riser, Jeffrey Gitt, James Stankiewicz
Multiple Sclerosis and Related Disorders. 2025-03-08

Press Mentions

Severe MS: UB Researchers Report Findings on Patients with Rare Form of DiseaseOctober 23rd, 2024

External Links

Weinstock-Guttmanhttps://www.ncbi.nlm.nih.gov/m/pubmed/